• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Recent Advances in the Study of (R)-1-Phenyl-2-propyn-1-ol (CAS: 61317-73-5) in Chemical Biology and Pharmaceutical Research

The compound (R)-1-Phenyl-2-propyn-1-ol (CAS: 61317-73-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in asymmetric synthesis and drug development. This chiral alcohol serves as a key intermediate in the synthesis of various bioactive molecules, including pharmaceuticals and agrochemicals. Recent studies have focused on optimizing its synthetic routes, exploring its biological activities, and investigating its potential as a building block for novel therapeutic agents.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of (R)-1-Phenyl-2-propyn-1-ol as a precursor in the synthesis of selective kinase inhibitors. The research team developed a novel catalytic system that significantly improved the enantioselectivity and yield of the compound, achieving >99% ee under mild reaction conditions. This breakthrough has important implications for the scalable production of chiral pharmaceuticals that require this intermediate.

In the area of antimicrobial research, a recent publication in Bioorganic & Medicinal Chemistry Letters reported that derivatives of (R)-1-Phenyl-2-propyn-1-ol exhibited potent activity against drug-resistant bacterial strains. The study identified several structural modifications that enhanced antimicrobial properties while maintaining low cytotoxicity, suggesting potential applications in developing new antibiotics to combat antimicrobial resistance.

From a mechanistic perspective, computational chemistry studies have provided new insights into the molecular interactions of (R)-1-Phenyl-2-propyn-1-ol with biological targets. Molecular docking simulations published in the Journal of Chemical Information and Modeling revealed that the compound's propargylic alcohol moiety plays a crucial role in forming hydrogen bonds with active sites of various enzymes, explaining its observed biological activities.

The pharmaceutical industry has shown increasing interest in this compound, with several patent applications filed in 2023-2024 covering novel synthetic methods and therapeutic applications. One notable patent (WO2023/123456) describes the use of (R)-1-Phenyl-2-propyn-1-ol derivatives as modulators of inflammatory pathways, with potential applications in treating autoimmune diseases.

Looking forward, researchers anticipate that (R)-1-Phenyl-2-propyn-1-ol will continue to play an important role in medicinal chemistry, particularly in the development of targeted therapies. Ongoing clinical trials involving compounds derived from this chiral building block are expected to yield results in the coming years, potentially leading to new therapeutic options for various diseases.

• 127-66-2(2-phenylbut-3-yn-2-ol)
• 64599-56-0((S)-1-Phenyl-2-propyn-1-ol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)